Tag:

VGX Pharmaceuticals

Latest Headlines

Latest Headlines

Inovio, VGX ink hep B and C vaccine deal

October 13, 2011 | By
Blue Bell, PA-based Inovio Pharmaceuticals and VGX International will collaborate on the development of Inovio's synthetic vaccines for hepatitis B and hepatitis C. Financial details of the deal were

VGX Pharma gets $23M NIH grant for HIV vax

October 6, 2008 | By
Start-up VGX Pharmaceuticals has been awarded $23 million from the National Institutes of Health to complete the development and manufacturing of their preventive HIV vaccine, which is now in the

Inovio merging with VGX to work on DNA vaccines

FierceBiotech | July 8, 2008
DNA vaccine delivery company Inovio Biomedical is merging with DNA vaccine developer VGX Pharmaceuticals. Inovio is issuing new shares for the deal, which should close before the end of the year. The
Related Tags

VGX Pharmaceuticals Press Releases

  • VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation
  • VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation
  • VGX Pharmaceuticals Commences Follow-on Phase I Study for Novel Oral Anti-Inflammatory Drug Targeting Rheumatoid Arthritis and T
Press Releases
  • Oculus Innovative Sciences Receives FDA Clearance for Novel Atopic Dermatitis Dermatology Product
  • Augmenix Announces Publication of SpaceOAR System Clinical Trial Results in Leading Radiation Oncology Journal
  • Navidea Reports Manocept Study Results in Rheumatoid Arthritis Presented at EULAR 2015
  • Beckman Coulter Diagnostics Obtains CE Marks for New HCV RNA and HIV-1 Assays on DxN VERIS Molecular Diagnostics System
  • Medtronic Initiates U.S. Launch of Fortrex(TM) PTA Balloon
  • More Press Releases
Sponsored Links